# clm_F3847C54AA19

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 2,048,400,000 United States dollar  
valid_from: 2019-09-30  
valid_to: 2020-03-31  
published: 2019-11-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0BEF5E393370  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 2,048,400,000 United States dollar", as of 2019-09-30 (until 2020-03-31). Claim clm_F3847C54AA19, https://asof.is/claim/clm_F3847C54AA19, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2019, filed 2019-11-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm (primary, SEC EDGAR 10-Q Q3 FY2019, published 2019-11-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,933,700,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_F3847C54AA19](/claim/clm_F3847C54AA19.md) | [clm_D84F29A094C8](/claim/clm_D84F29A094C8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.